
Calcium L-5-methyltetrahydrofolate

What is the difference between L-methylfolate and folic acid?
The key difference is that folic acid is the synthetic, inactive form that must be converted by the body into L-methylfolate, whereas L-methylfolate is the biologically active form that the body can use immediately.
Because L-methylfolate is already active, it is beneficial for individuals with MTHFR gene mutations who struggle to convert folic acid, and it is considered safer as it does not mask a vitamin B12 deficiency.

|
Product name: |
Calcium L-5-methyltetrahydrofolate |
|
Synonyms: |
Calcium levomefolate;N-[4-[[(2-Amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6 pteridinyl)methyl]amino]benzoyl]-L-glutamic acid calcium salt; |
|
Formula: |
C20H23CaN7O6 |
|
Molecular weight: |
497.52 |
|
CAS number: |
151533-22-1 |
|
Appearance |
White to light yellow crystalline powder |
|
Technology: |
Synthetic/enzymatic method |
|
Assay: |
95.00%~102.00% |
|
L-5-MTHF: |
72.00%~87.00% |
|
Calcium(Anhydrous and solvent free): |
7.00%~8.50% |
|
MOQ: |
1kg |
|
Certification: |
ISO9001, FSSC22000 |
|
Package: |
1kg/bag or customized |
|
Shelf Life: |
24 Months under room temperature |
|
Application |
Food supplement, food additive, cosmetic |
|
Storage: |
Store in a well-closed container away from moisture and direct sunlight. |
Mechanism of Action
Unlike synthetic folic acid, which requires metabolic activation in the body, L-5-MTHF is the primary biologically active form of folate .
Direct Utilization: Folic acid must be reduced by the enzyme dihydrofolate reductase to become active. L-5-MTHF bypasses this step and is ready for immediate use at the cellular level .
Key Biochemical Role: It acts as a methyl-group donor, working in conjunction with vitamin B12, to convert the amino acid homocysteine to methionine . This process is vital for DNA reproduction, regulation of homocysteine levels, and proper cell division.

|
Product characteristics |
|
|
Product name: |
Calcium L-5-methyltetrahydrofolate(L-5-MTHF-Ca) |
|
Synonyms: |
Calcium levomefolate;N-[4-[[(2-Amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid calcium salt; |
|
Molecular formula: |
C20H23CaN7O6 |
|
Molecular weight: |
497.52 |
|
CAS number: |
151533-22-1 |
|
Molecular structure: |
|
|
Product profile |
|
|
Appearance: |
White to light yellow crystalline powder |
|
Water: |
6.00~17.00% |
|
Particle size: |
NLT 90% pass 80 mesh |
|
Bulk density: |
NLT 0.20g/ml |
|
Residue Solvents: |
|
|
Ethanol: |
NMT 5,000 ppm |
|
2-Propanol: |
NMT 5,000 ppm |
|
Assay(Anhydrous and solvent free): |
95.00%~102.00% |
|
L-5-MTHF: |
72.00%~87.00% |
|
Calcium(Anhydrous and solvent free): |
7.00%~8.50% |
|
Total Related compounds |
NMT 2.50% |
|
4-aminobenzoyl-glutamic acid : |
NMT 0.50% |
|
4a-Hydroxy-5-methyltetrahydrofolic acid: |
NMT 1.00% |
|
(6R and 6S)Mefox: |
NMT 1.00% |
|
Tetraphydrofolic acid: |
NMT 0.50% |
|
7,8-dihydrofolic acid: |
NMT 0.50% |
|
Folic acid: |
NMT 0.50% |
|
5,10-methultetrahydrofolic acid: |
NMT 0.50% |
|
5-methultetrahydrofolic acid: |
NMT 0.50% |
|
Dimethyltetrahydrofolic acid: |
NMT 0.15% |
|
Enantiomeric impurity(D-5-methyltetrahydrofolate): |
NMT 1.00% |
|
Boron: |
NMT 50.00 ppm |
|
Platinum: |
NMT 10.00 ppm |
|
Chloride: |
NMT 0.50% |
|
Arsenic: |
NMT 1.50 ppm |
|
Cadmium: |
NMT 0.50 ppm |
|
Lead: |
NMT 1.00 ppm |
|
Mercury: |
NMT 1.50 ppm |
|
Microbial limit |
|
|
Total Plate count: |
NMT 1,000 cfu/g |
|
Yeast&Mold: |
NMT 100 cfu/g |
|
E.coli: |
Negative |
|
Salmonella: |
Negative |
|
Staphylococcus aureus: |
Negative |
|
Pseudomonas aeruginosa: |
Negative |
|
Candida albicans: |
Negative |
|
Clostridia |
Negative |
|
Packaging |
1 kg/Bag or Customized |
|
Storage |
Keep container unopened in cool, dry place |
|
Shelf life |
24 month with packing unopened |

The unique properties of L-5-MTHF-Ca make it a versatile ingredient across several sectors.
Dietary Supplements and Nutraceuticals: Widely used in prenatal vitamins to support maternal and fetal health and reduce the risk of neural tube defects . It is also included in supplements for cardiovascular health (to manage homocysteine) and mental wellness, as it is used in formulations for depression .
Pharmaceuticals: Utilized as an active pharmaceutical ingredient (API) in medicinal products, including certain oral contraceptives combined with drospirenone/ethinyl estradiol to ensure adequate folate levels in women of child-bearing age . It is also used in preparations to support folic acid deficiency and as an antidote to folate antagonists .
Food and Beverage Industry: Used for the fortification of foods like cereals and grain products. Research has shown that microencapsulated L-5-MTHF can be successfully used to fortify wheat rolls, effectively increasing blood folate concentrations without the stability issues previously associated with baking.

L-5-MTHF-Ca is engineered to overcome the limitations of both folic acid and earlier folate salts.
High Bioavailability: As the active form, it is at least as effective as folic acid in improving folate status, with studies showing comparable physiological activity at equimolar doses . It is also described as better absorbed than regular folic acid .
Enhanced Stability: The calcium salt form, particularly the patented C-crystal form, provides the stability required for use in supplements and fortified foods. It offers over 2 years of stability at room temperature, a significant improvement .
Improved Solubility and Potency: Advanced crystalline forms are designed for better dissolution, higher potency, and better particle size distribution compared to older formulations like the I-crystal form or glucosamine salts . While standard calcium salt has a solubility of about 1.07%, derivatives like basic amino acid salts have been developed with solubility over 50%.
Product Advantages
Choosing L-5-MTHF-Ca over folic acid offers distinct health and safety benefits.
Safer for B12 Deficiency: High intake of folic acid can correct the anemia caused by vitamin B12 deficiency, effectively "masking" this condition while allowing neurological damage to progress. L-5-MTHF does not mask the hematological symptoms of B12 deficiency, making it a safer alternative .
Ideal for Genetic Variations: It is the preferred form for individuals with MTHFR gene mutations, which impair the body's ability to convert folic acid into its active form . By providing the active form directly, it ensures everyone can benefit, regardless of their genetics.
Fewer Drug Interactions: L-5-MTHF has a reduced potential for interaction with drugs that inhibit dihydrofolate reductase (e.g., methotrexate), as it does not require this enzyme for activation.

Q1: How is Calcium L-5-methyltetrahydrofolate different from folic acid?
A: Folic acid is a synthetic, inactive vitamin that must be converted by the body into the active form (L-5-MTHF). Calcium L-5-methyltetrahydrofolate is already the active form, so it can be used directly by the body without any metabolic steps. This makes it a more efficient and universally beneficial option, especially for people with genetic variations that hinder the conversion process.
Q2: Is it safe for long-term use?
A: Yes, L-5-MTHF is the form of folate normally found in the circulation and used by the body. It offers safety advantages over folic acid, particularly in not masking vitamin B12 deficiency . According to safety data sheets, the substance itself is not classified as hazardous, though standard laboratory and manufacturing safety practices should always be followed.
Q3: Why is this form better for prenatal health?
A: It is highly effective at improving folate status, which is crucial for preventing neural tube defects in the developing fetus . Furthermore, because it is the active form, it ensures that both the mother and baby receive the full benefit, regardless of the mother's ability to metabolize folic acid.
Hot Tags: calcium l-5-methyltetrahydrofolate, China calcium l-5-methyltetrahydrofolate manufacturers, suppliers, factory
Send Inquiry

